Web Analytics
Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer — And Plunges | Deepscope News
MARKET

Select Market Data Region

 April 1, 2026 08:59 PM  finance.yahoo.com Negative

Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer — And Plunges

Image

Oric stock crashed Wednesday after the company indicated its prostate cancer treatment is roughly as effective as a competitor.

Continue Reading

Read original source